Search

Your search keyword '"Bolli, Martin"' showing total 394 results

Search Constraints

Start Over You searched for: Author "Bolli, Martin" Remove constraint Author: "Bolli, Martin"
394 results on '"Bolli, Martin"'

Search Results

101. S1P1Modulator-Induced GαiSignaling and β-Arrestin Recruitment Are Both Necessary to Induce Rapid and Efficient Reduction of Blood Lymphocyte Count In Vivo

102. Novel S1P1 Receptor Agonists − Part 3: From Thiophenes to Pyridines

103. Novel S1P1 Receptor Agonists - Part 2: From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl Substituted Thiophenes

104. Novel S1P1 Receptor Agonists – Part 1: From Pyrazoles to Thiophenes

105. Sphingosine 1-Phosphate (S1P) Receptor Agonists Mediate Pro-fibrotic Responses in Normal Human Lung Fibroblasts via S1P2 and S1P3 Receptors and Smad-independent Signaling

106. The metabolism of the dual endothelin receptor antagonist macitentan in rat and dog.

107. Crystal structure of a parallel-standed duplex of a deoxycytidylyl-(3'-5')-deoxycytidine analogue containing intranucleosidyl C(3')-C(5') Ethylene Bridges

108. The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an Orally Active, Potent Dual Endothelin Receptor Antagonist

112. 2-Imino-thiazolidin-4-one Derivatives as Potent, Orally Active S1P1Receptor Agonists

113. Intranodal Immunization With a Vaccinia Virus Encoding Multiple Antigenic Epitopes and Costimulatory Molecules in Metastatic Melanoma

114. Differential Responsiveness to IL-2, IL-7, and IL-15 Common Receptor γ Chain Cytokines by Antigen-specific Peripheral Blood Naive or Memory Cytotoxic CD8+ T Cells From Healthy Donors and Melanoma Patients

116. Pharmacology of Macitentan, an Orally Active Tissue-Targeting Dual Endothelin Receptor Antagonist

117. The Timing of Surgical Antimicrobial Prophylaxis

118. Culture of melanoma cells in three-dimensional architectures results in impaired immunorecognition by cytotoxic T lymphocytes specific for Melan-A/MART-1 tumor associated antigen

119. Novel Benzo[1,4]diazepin-2-one Derivatives as Endothelin Receptor Antagonists

120. Immunothérapie active spécifique du mélanome

121. Pentopyranosyl Oligonucleotide Systems. 9th Communication

125. Prognostic relevance of MAGE‐A4 tumor antigen expression in transitional cell carcinoma of the urinary bladder: A tissue microarray study

126. Distinct ETA Receptor Binding Mode of Macitentan As Determined by Site Directed Mutagenesis.

127. Novel S1P1ReceptorAgonists − Part3: From Thiophenes to Pyridines.

128. Novel S1P1ReceptorAgonists - Part 2:From Bicyclo[3.1.0]hexane-Fused Thiophenes to Isobutyl SubstitutedThiophenes.

129. Novel S1P1ReceptorAgonists – Part1: From Pyrazoles to Thiophenes.

145. The Discovery of N-[5-(4-Bromophenyl)-6-[2-[(5-bromo-2-pyrimidinyl)oxy]ethoxy]-4-pyrimidinyl]-N′-propylsulfamide (Macitentan), an OrallyActive, Potent Dual Endothelin Receptor Antagonist.

147. Impact of Positive Lymph Nodes after Systematic Perihilar Lymphadenectomy in Colorectal Liver Metastases.

Catalog

Books, media, physical & digital resources